Two Cases of Reversible Neutropenia Associated with Olanzapine-Valproate Combination Treatment / 신경정신의학
Journal of Korean Neuropsychiatric Association
; : 653-656, 2010.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-53581
Responsible library:
WPRO
ABSTRACT
The novel antipsychotic, olanzapine, has structural and pharmacological properties similar to clozaine. Antipsychotic drugs, as well as mood stabilizers, can cause neutropenia, which can progress to life-threatening agranulocytosis if the medication is not discontinued. We report two cases of reversible neutropenia associated with a olanzapine-valproate combination treatment. This report suggests that patients treated with the combination of olanzapine and valproate should be monitored for the occurrence of leukopenia and neutropenia.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Antipsychotic Agents
/
Benzodiazepines
/
Valproic Acid
/
Agranulocytosis
/
Leukopenia
/
Neutropenia
Limits:
Humans
Language:
Korean
Journal:
Journal of Korean Neuropsychiatric Association
Year:
2010
Document type:
Article